NATALIA MORENO: Open Payments
NPI 1679112155 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 41 payments from 15 companies in 2025. Trend: 2023 $760 · 2024 $1,879 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $170 |
| Lilly USA, LLC | 8 | $137 |
| Abbott Laboratories | 3 | $77 |
| PFIZER INC. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| SANOFI-AVENTIS U.S. LLC | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $35 |
| Averitas Pharma Inc. | 1 | $30 |
| Exact Sciences Corporation | 1 | $21 |
Products named: MOUNJARO, Wegovy, FREESTYLE LIBRE 3, Ozempic, TZIELD, PREVNAR 20, BREZTRI, VRAYLAR.
Industry payments across FL — which companies pay providers there.
